Artal Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-250,000	Closed	-$23.7M	–	131
2024 Q1	$23.7M	Buy	+250,000	New	+$23.2M	0.6%	24
2023 Q3	–	Sell	-1,000,000	Closed	-$83.2M	–	120
2023 Q2	$83.2M	Buy	+1,000,000	New	+$83.6M	2.58%	5
2022 Q4	–	Sell	-5,000,000	Closed	-$397M	–	137
2022 Q3	$397M	Buy	+5,000,000	New	+$422M	16.93%	1
2022 Q1	–	Sell	-1,000,000	Closed	-$112M	–	149
2021 Q4	$112M	Buy	+1,000,000	New	+$121M	3.04%	6
2021 Q2	–	Sell	-500,000	Closed	-$67.8M	–	162
2021 Q1	$67.8M	Buy	+500,000	New	+$74.9M	1.2%	22
2020 Q2	–	Sell	-500,000	Closed	-$38.7M	–	140
2020 Q1	$38.7M	Buy	+500,000	New	+$44.3M	1.64%	18
2019 Q4	–	Sell	-250,000	Closed	-$19.1M	–	106
2019 Q3	$19.1M	Buy	+250,000	New	+$20.8M	0.76%	25
2018 Q4	–	Sell	-200,000	Closed	-$19.2M	–	116
2018 Q3	$19.2M	Buy	+200,000	New	+$19.4M	0.5%	30
2018 Q2	–	Sell	-500,000	Closed	-$43.9M	–	119
2018 Q1	$43.9M	Buy	500,000 +100,000	+25%	+$9.13M	0.55%	19
2017 Q4	$33.9M	Buy	+400,000	New	+$33.5M	0.51%	16
2016 Q1	–	Sell	-150,000	Closed	-$10.5M	–	80
2015 Q4	$10.5M	Sell	150,000 -300,000	-67%	-$20.5M	0.2%	48
2015 Q3	$28M	Buy	+450,000	New	+$35.5M	0.63%	23
2014 Q1	–	Sell	-450,000	Closed	-$19.5M	–	110
2013 Q4	$19.5M	Buy	+450,000	New	+$18.6M	0.7%	27